{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-012443","form_type":"8-K","ticker":"ETON","cik":"0001710340","company_name":"Eton Pharmaceuticals, Inc.","filed_at":"2024-04-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.691054+00:00","generated_at":"2026-06-03T19:05:21.832652+00:00","sec_items":[],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Eton cancels $13.1M equity raise and credit expansion after losing Eiger auction","bullets":["Planned to issue 1,287,500 common shares at $3.50 and pre-funded warrants for 2,462,500 shares.","Also planned to expand credit facility from $21.9M to $27.0M with a lender warrant for 358,976 shares.","All transactions were contingent on winning an auction for Eiger BioPharmaceuticals assets on April 17, 2024.","Eton was not the successful bidder; therefore all agreements were cancelled and are void.","No underwriters were used; the offerings were exempt under Regulation D Rule 506."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-012443","json":"https://secwatch.observer/filing/0001437749-24-012443.json","markdown":"https://secwatch.observer/filing/0001437749-24-012443.md","text":"https://secwatch.observer/filing/0001437749-24-012443.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1710340/000143774924012443/0001437749-24-012443-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1710340/000143774924012443/eton20240412_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T19:05:21.832652+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}